Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Diabetes, a disease in which carbohydrate and lipid metabolism are regulated improperly by insulin, is a serious worldwide health issue. Insulin is secreted from pancreatic beta cells in response to elevated plasma glucose, with various factors modifying its secretion. Free fatty acids (FFAs) provide an important energy source as nutrients, and they also act as signalling molecules in various cellular processes, including insulin secretion. Although FFAs are thought to promote insulin secretion in an acute phase, this mechanism is not clearly understood. Here we show that a G-protein-coupled receptor, GPR40, which is abundantly expressed in the pancreas, functions as a receptor for long-chain FFAs. Furthermore, we show that long-chain FFAs amplify glucose-stimulated insulin secretion from pancreatic beta cells by activating GPR40. Our results indicate that GPR40 agonists and/or antagonists show potential for the development of new anti-diabetic drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The binding and subsequent interaction of long-chain FFAs with the G-protein-coupled free fatty acid receptor (FFAR) 1 in the pancreatic β-cells leads to the activation of phospholipase C. PLC then hydrolyzes phosphatidylinositol-4,5-bisphosphate (PIP2) to diacylglycerol and inositol-1,4,5-triphosphate (IP3), with the latter docking on a calcium channel in the endoplasmic reticulum. The subsequent”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [94]
In the citing paper
“Activation of FFAR1 elevates [Ca2+]i and stimulates insulin secretion in a glucose-dependent fashion (306).”
From Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men (2018) · cites this paper as [306]
Citations
Cites
Method for the Isolation of Intact Islets of Langerhans from the Rat Pancreas
Lacy, P. E., & Kostianovsky, M. (1967) · Diabetes · doi:10.2337/diab.16.1.35 · Cited by 2,751
A G Protein-coupled Receptor Responsive to Bile Acids
Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209706200 · Cited by 1,628 · cited 1×
“MAP kinase MAP kinase activation in CHO and MIN6 cells after treatment with 10 µM of each FFA was determined as described previousl”
MethodSelf-citationCloning of the β Cell High-Affinity Sulfonylurea Receptor: a Regulator of Insulin Secretion
Aguilar-Bryan, L., Nichols, C. G., Wechsler, S. W., Clement, J. P., Boyd, A. E., González, G., Herrera-Sosa, H., Nguy, K., Bryan, J., & Nelson, D. A. (1995) · Science · doi:10.1126/science.7716547 · Cited by 1,315
MIYAZAKI, J.-I., ARAKI, K., YAMATO, E., IKEGAMI, H., ASANO, T., SHIBASAKI, Y., OKA, Y., & YAMAMURA, K.-I. (1990) · Endocrinology · doi:10.1210/endo-127-1-126 · Cited by 1,266
Triggering and amplifying pathways of regulation of insulin secretion by glucose.
Henquin, J. C. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1751 · Cited by 1,201 · cited 1×
“Insulin is secreted from pancreatic β cells in response to elevated plasma glucose, with various factors modifying its secretio”
BackgroundThe Orphan G Protein-coupled Receptor GPR40 Is Activated by Medium and Long Chain Fatty Acids
Briscoe, C. P., Tadayyon, M., Andrews, J. L., Benson, W. G., Chambers, J. K., Eilert, M. M., Ellis, C., Elshourbagy, N. A., Goetz, A. S., Minnick, D. T., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211495200 · Cited by 1,104 · cited 1×
“Although it has been reported that FFAs activate GPR40 and that GPR40 is highly expressed in pancreatic β cell”
BackgroundFree Fatty Acids and Pathogenesis of Type 2 Diabetes Mellitus
BERGMAN, R., & ADER, M. (2000) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(00)00323-4 · Cited by 622 · cited 1×
“: in short-term exposure, FFAs enhance GSIS but under long-term exposure they act to attenuate it; an effect called lipotoxicit”
BackgroundA prolactin-releasing peptide in the brain
Hinuma, S., Habata, Y., Fujii, R., Kawamata, Y., Hosoya, M., Fukusumi, S., Kitada, C., Masuo, Y., Asano, T., Matsumoto, H., et al. (1998) · Nature · doi:10.1038/30515 · Cited by 563 · cited 1×
“Previously, we established a strategy to identify ligands by detecting signal transductions in cells expressing orphan GPCR”
BackgroundSelf-citationMETABOLIC COUPLING FACTORS IN PANCREATIC β-CELL SIGNAL TRANSDUCTION
Newgard, C. B., & McGarry, J. D. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.003353 · Cited by 531 · cited 1×
“Although several studies have proposed possible mechanisms for FFA-amplified GSIS—for example, that FFAs might simply provide energy to β cells or, alternatively, that the metabolites of FFAs, fatty acyl-coenzyme A molecules, act to stimulate insulin secretio”
BackgroundWank, S. A., Harkins, R., Jensen, R. T., Shapira, H., de Weerth, A., & Slattery, T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.3125 · Cited by 403 · cited 1×
“Its expression was comparable to that of type A cholecystokinin recepto”
Result
Cited by
Items 201–300 of 1,001
Christiansen, E., Urban, C., Merten, N., Liebscher, K., Karlsen, K. K., Hamacher, A., Spinrath, A., Bond, A. D., Drewke, C., Ullrich, S., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8010178 · Cited by 133
Identification of Residues Important for Agonist Recognition and Activation in GPR40
Sum, C. S., Tikhonova, I. G., Neumann, S., Engel, S., Raaka, B. M., Costanzi, S., & Gershengorn, M. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705077200 · Cited by 136
Almog, T., Lazar, S., Reiss, N. A., Etkovitz, N., Milch, E., Rahamim, N., Dobkin-Bekman, M., Rotem, R., Kalina, M., Ramon, J., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710492200 · Cited by 135
Reduction in Voltage-Gated K+ Currents in Primary Cultured Rat Pancreatic β-Cells by Linoleic Acids
Feng, D. D., Luo, Z., Roh, S.-G., Hernandez, M., Tawadros, N., Keating, D. J., & Chen, C. (2006) · Endocrinology · doi:10.1210/en.2005-0225 · Cited by 124
Alquier, T., Peyot, M.-L., Latour, M. G., Kebede, M., Sorensen, C. M., Gesta, S., Ronald Kahn, C., Smith, R. D., Jetton, T. L., Metz, T. O., et al. (2009) · Diabetes · doi:10.2337/db09-0362 · Cited by 122
“GPR40 expression has been detected in the ileum (1,2), monocytes (1), pancreatic -cells (36), some areas of the brain (1,37), entero-endocrine cells (38), and osteoclasts (39), albeit at much lower levels than in -cells.”
BackgroundInfluentialMarowsky, A., Burgener, J., Falck, J. R., Fritschy, J., & Arand, M. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.06.033 · Cited by 139
Sykaras, A. G., Demenis, C., Case, R. M., McLaughlin, J. T., & Smith, C. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042373 · Cited by 126
“Transcripts encoding LCFA receptors PLoS ONE | www.plosone.org 3 August 2012 | Volume 7 | Issue 8 | e42373 GPR40/FFAR1 and GPR120/O3FAR1 were expressed in I-cells: Gpr40/Ffar1 mRNA was highly enriched in I-cells and could not be detected in non I-cells (eGFP2 cells); Gpr120/O3far1 mRNA was detected in both I-cells and…”
BackgroundInfluentialMobraten, K., Haug, T. M., Kleiveland, C. R., & Lea, T. (2013) · Lipids in Health and Disease · doi:10.1186/1476-511x-12-101 · Cited by 121
“During digestion, dietary triglycerides are cleaved into monoglycerides and free fatty acids (FFAs).”
BackgroundInfluentialp38 Mitogen-activated Protein Kinase Mediates Free Fatty Acid-induced Gluconeogenesis in Hepatocytes
Collins, Q. F., Xiong, Y., Lupo, E. G., Liu, H.-Y., & Cao, W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602177200 · Cited by 122
Incretins: their physiology and application in the treatment of diabetes mellitus
Tasyurek, H. M., Altunbas, H. A., Balci, M. K., & Sanlioglu, S. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2501 · Cited by 121
“lin secretion [132], GPCR-40-knockout mice displayed reduced incretin response to high-fat diet [133].”
BackgroundCa2+ microdomains and the control of insulin secretion
Rutter, G. A., Tsuboi, T., & Ravier, M. A. (2006) · Cell Calcium · doi:10.1016/j.ceca.2006.08.015 · Cited by 127
Lipid receptors and islet function: therapeutic implications?
Kebede, M. A., Alquier, T., Latour, M. G., & Poitout, V. (2009) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01114.x · Cited by 122
Cytochrome P450-derived eicosanoids and heart function
Jamieson, K. L., Endo, T. H., Darwesh, A. M., Samokhvalov, V., & Seubert, J. M. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.05.005 · Cited by 128
“A plethora of studies reported that n-3 PUFAmodulates insulin secretion from pancreatic β-cells through GPR40 (Briscoe et al., 2003; Itoh et al., 2003; Mancini & Poitout, 2013; Salehi et al., 2005; Wang & Chan, 2015).”
Identification and characterization of an endogenous chemotactic ligand specific for FPRL2
Migeotte, I., Riboldi, E., Franssen, J.-D., Grégoire, F., Loison, C., Wittamer, V., Detheux, M., Robberecht, P., Costagliola, S., Vassart, G., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041277 · Cited by 120
Mazhar, M., Zhu, Y., & Qin, L. (2023) · Foods · doi:10.3390/foods12051023 · Cited by 119
“Medium (FFAR-1) and long-chain (FFAR-4) fatty acids were found to positively respond to inflammation and insulin secretion [112].”
BackgroundN-Formylated humanin activates both formyl peptide receptor-like 1 and 2
Harada, M., Habata, Y., Hosoya, M., Nishi, K., Fujii, R., Kobayashi, M., & Hinuma, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.09.046 · Cited by 131
Self-citationLin, D. C.-H., Guo, Q., Luo, J., Zhang, J., Nguyen, K., Chen, M. J., Tran, T., Dransfield, P. J., Brown, S. P., Houze, J. B., et al. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.079640 · Cited by 118
“Several reports have demonstrated that the FFA1 receptor is activated by both medium- and long-chain fatty acids (Briscoe et al., 2003; Itoh et al., 2003) and couples preferentially to G q (Latour et al., 2007; Stoddart et al., 2007) to stimulate phospholipase C activity (Briscoe et al., 2003).”
BackgroundSamsulrizal, N., Goh, Y. M., Ahmad, H., Dom, S. M., Azmi, N. S., Zin, N. S. N. M., & Ebrahimi, M. M. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-1762-8 · Cited by 121
Epidemic Inflammation: Pondering Obesity
Nathan, C. (2008) · Molecular Medicine · doi:10.2119/2008-00038.nathan · Cited by 119
Glucose sensing in the intestinal epithelium
Dyer, J., Vayro, S., King, T. P., & Shirazi‐Beechey, S. P. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03721.x · Cited by 117
Wu, Q., Comi, T. J., Li, B., Rubakhin, S. S., & Sweedler, J. V. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b01021 · Cited by 119
Paulsson, J. F., Andersson, A., Westermark, P., & Westermark, G. T. (2006) · Diabetologia · doi:10.1007/s00125-006-0206-7 · Cited by 133
“NEFAs can act directly on the beta cells through the cell surface receptor GPR40 and enhance glucose-stimulated insulin secretion [42].”
BackgroundLack of FFAR1/GPR40 Does Not Protect Mice From High-Fat Diet–Induced Metabolic Disease
Lan, H., Hoos, L. M., Liu, L., Tetzloff, G., Hu, W., Abbondanzo, S. J., Vassileva, G., Gustafson, E. L., Hedrick, J. A., & Davis, H. R. (2008) · Diabetes · doi:10.2337/db08-0596 · Cited by 116
Effects of Dietary Fatty Acids in Pancreatic Beta Cell Metabolism, Implications in Homeostasis
Acosta-Montaño, P., & García‐González, V. (2018) · Nutrients · doi:10.3390/nu10040393 · Cited by 127
“Additionally, downregulation of FFAR1 by RNAi caused impaired FA augmentation of insulin secretion [46].”
BackgroundChemistry and biology of sphingolipids
Liao, J., Tao, J., Lin, G., & Liu, D. (2005) · Tetrahedron · doi:10.1016/j.tet.2005.02.075 · Cited by 117
Tanaka, T., Yano, T., Adachi, T., Koshimizu, T., Hirasawa, A., & Tsujimoto, G. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-007-0250-y · Cited by 139
Ulven, T., & Christiansen, E. (2015) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071714-034410 · Cited by 114
Oral Detection of Short-, Medium-, and Long-Chain Free Fatty Acids in Humans
Mattes, R. D. (2008) · Chemical Senses · doi:10.1093/chemse/bjn072 · Cited by 118
“Expanding the types of effective stimuli to shorter medium-chain fatty acids is GPCR40, which binds these species, as well as long-chain unsaturated and saturated fatty acids (Itoh et al. 2003).”
BackgroundStoddart, L. A., Smith, N. J., Jenkins, L., Brown, A. J., & Milligan, G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805601200 · Cited by 113
López, S., Bermúdez, B., Ortega‐Gómez, A., Varela, L. M., Pacheco, Y. M., Villar, J. R., Abia, R., & Muriana, F. J. G. (2011) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.003251 · Cited by 116
“A variety of fatty acids have been found to acutely activate FFAR1 within the physiologic range in vitro (23).”
BackgroundChristiansen, E., Watterson, K. R., Stocker, C. J., Sokol, E., Jenkins, L., Simon, K., Grundmann, M., Petersen, R. K., Wargent, E. T., Hudson, B. D., et al. (2015) · British Journal of Nutrition · doi:10.1017/s000711451500118x · Cited by 115
Short Chain Fatty Acids, pancreatic dysfunction and type 2 diabetes
Mandaliya, D. K., & Seshadri, S. (2019) · Pancreatology · doi:10.1016/j.pan.2019.01.021 · Cited by 110
Diabetic Retinopathy: The Role of Mitochondria in the Neural Retina and Microvascular Disease
Miller, D. J., Cascio, M. A., & Rosca, M. G. (2020) · Antioxidants · doi:10.3390/antiox9100905 · Cited by 122
Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators
Grundmann, M., Bender, E., Schamberger, J., & Eitner, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041763 · Cited by 120
“In accordance with the deorphanization of FFAR1 as a long-chain fatty acid sensing receptor, focus was put on the pancreatic expression of FFAR1, especially on β-cells, and its involvement in the secretion mechanisms of insulin [16,18].”
BackgroundInterleukin-6 Enhances Glucose-Stimulated Insulin Secretion From Pancreatic β-Cells
Suzuki, T., Imai, J., Yamada, T., Ishigaki, Y., Kaneko, K., Uno, K., Hasegawa, Y., Ishihara, H., Oka, Y., & Katagiri, H. (2011) · Diabetes · doi:10.2337/db10-0796 · Cited by 108
“Because FFAs are known to be potent insulinotropic factors (30), we evaluated plasma FFA concentrations.”
Synthesis and activity of small molecule GPR40 agonists
Garrido, D. M., Corbett, D. F., Dwornik, K. A., Goetz, A. S., Littleton, T. R., McKeown, S. C., Mills, W. Y., Smalley, T. L. J., Briscoe, C. P., & Peat, A. J. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.01.007 · Cited by 111
Kim, H.-S., Hwang, Y.-C., Koo, S.-H., Park, K. S., Lee, M.-S., Kim, K.-W., & Lee, M.-K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0050128 · Cited by 110
“Accumulating evidence indicates that GPR40 mediates the majority of both acute and chronic effects of FFAs on insulin secretion, including the amplification of GSIS [21,23–29], and the receptor has been suggested to be involved in the control of cell proliferation via extracellular signal-related kinase (ERK), phospho…”
BackgroundExpression of free fatty acid receptor GPR40 in the central nervous system of adult monkeys
Ma, D., Tao, B., Warashina, S., Kotani, S., Lu, L., Kaplamadzhiev, D. B., Mori, Y., Tonchev, A. B., & Yamashima, T. (2007) · Neuroscience Research · doi:10.1016/j.neures.2007.05.001 · Cited by 128
“The latter are known to be important not only as energy sources but also as endogenous ligands for GPR (Briscoe et al., 2003; Itoh et al., 2003; Kotarsky et al., 2003).”
BackgroundGPCR crystal structures: Medicinal chemistry in the pocket
Shonberg, J., Kling, R. C., Gmeiner, P., & Löber, S. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.12.034 · Cited by 137
G protein-coupled receptors as targets for anti-diabetic therapeutics
Oh, D. Y., & Olefsky, J. M. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.4 · Cited by 117
Morley, T. S., Xia, J. Y., & Scherer, P. E. (2015) · Nature Communications · doi:10.1038/ncomms8906 · Cited by 109
“This β3 adrenergic receptor stimulation leads to enhanced lipolysis, as well as a rapid and massive release of insulin (10).”
BackgroundHudson, B. D., Due-Hansen, M. E., Christiansen, E., Hansen, A. M., Mackenzie, A. E., Murdoch, H., Pandey, S. K., Ward, R. J., Marquez, R., Tikhonova, I. G., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.455337 · Cited by 113
“Although the long chain fatty acid receptors have received the most interest, FFA1 due to its ability to potentiate glucose-stimulated insulin release (1) and FFA4 for its ability to stimulate glucagon-like peptide-1 secretion (2) and to mediate the insulin-sensitizing and anti-inflammatory properties of n-3 fatty aci…”
BackgroundGender Differences in Insulin Resistance: New Knowledge and Perspectives
Ciarambino, T., Crispino, P., Guarisco, G., & Giordano, M. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45100496 · Cited by 128
“Initially, glucose along with elevated levels of free fatty acids (FFAs) leads to an increase in β -cell mass as a compensatory mechanism against IR [25].”
BackgroundRavnskjaer, K., Boergesen, M., Rubi, B., Larsen, J. K., Nielsen, T., Fridriksson, J., Maechler, P., & Mandrup, S. (2005) · Endocrinology · doi:10.1210/en.2004-1430 · Cited by 109
Targeting lipid GPCRs to treat type 2 diabetes mellitus — progress and challenges
Ghislain, J. J., & Poitout, V. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00459-w · Cited by 116
Fatty acid receptors as new therapeutic targets for diabetes
Rayasam, G. V., Tulasi, V. K., Davis, J. A., & Bansal, V. S. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.5.661 · Cited by 113
“No insights are available regarding the function of GPR40 in brain although it might imply a possible neurological function [17].”
BackgroundMethodInfluentialGPR40 is expressed in glucagon producing cells and affects glucagon secretion
Flodgren, E., Olde, B., Abaraviciene, S. M., Winzell, M. S., Åhrén, B., & Salehi, A. A. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.12.193 · Cited by 120
“Previous observations have shown that free fatty acids (FFAs) are not only important metabolites in the process of energy generation and storage, but also function as signalling molecules [1-3].”
BackgroundResultInfluentialContribution of adipocyte-derived factors to beta-cell dysfunction in diabetes
Zhao, Y.-F., Feng, D. D., & Chen, C. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.11.008 · Cited by 129
Albert, B. B., Derraik, J. G. B., Brennan, C. M., Biggs, J. B., Smith, G. C., Garg, M. L., Cameron-Smith, D., Hofman, P. L., & Cutfield, W. S. (2014) · Scientific Reports · doi:10.1038/srep06697 · Cited by 105
Pillaiyar, T., Köse, M., Sylvester, K., Weighardt, H., Thimm, D., Borges, G., Förster, I., von Kügelgen, I., & Müller, C. E. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01593 · Cited by 110
Bardhan, A., & Deiters, A. (2019) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2019.03.028 · Cited by 109
Oleic Acid Directly Regulates POMC Neuron Excitability in the Hypothalamus
Jo, Y.-H., Su, Y., Gutierrez-Juarez, R., & Chua, S. (2009) · Journal of Neurophysiology · doi:10.1152/jn.91294.2008 · Cited by 106
Defoßa, E., & Wagner, M. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.05.019 · Cited by 104
Activation of GPR40 as a Therapeutic Target for the Treatment of Type 2 Diabetes
Burant, C. F. (2013) · Diabetes Care · doi:10.2337/dcs13-2037 · Cited by 101
“Subsequent studies from two groups identified free fatty acids as ligands for the GPR40 protein (16,17), and GPR40 shows higher affinity for longer-chain fatty acids with a half-maximal effective concentration (EC50) in the 1–2 mmol/L range (17,18).”
BackgroundLin, C., Chao, H., Li, Z., Xu, X., Liu, Y., Bao, Z., Hou, L., Liu, Y., Wang, X., You, Y., et al. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.01.005 · Cited by 111
“Previous studies have shown that GPR40 is predominantly expressed in brain tissues and acts as an important receptor for free and long-chain fatty acids (Khan and He, 2015; Itoh et al., 2003; Nakamoto et al., 2013).”
Iakoubov, R., Izzo, A., Yeung, A., Whiteside, C. I., & Brubaker, P. L. (2007) · Endocrinology · doi:10.1210/en.2006-1403 · Cited by 103
Metabolic Inflammation-Differential Modulation by Dietary Constituents
Lyons, C., Kennedy, E., & Roche, H. (2016) · Nutrients · doi:10.3390/nu8050247 · Cited by 104
“OA and LA amplified glucose stimulated-insulin secretion through G-protein coupled receptor 40 (GPR40) [87].”
BackgroundATGL-dependent white adipose tissue lipolysis controls hepatocyte PPARα activity
Fougerat, A., Schoiswohl, G., Polizzi, A., Régnier, M., Wagner, C., Smati, S., Fougeray, T., Lippi, Y., Lasserre, F., Raho, I., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110910 · Cited by 111
GPR40, a free fatty acid receptor on pancreatic β cells, regulates insulin secretion
Itoh, Y., & Hinuma, S. (2005) · Hepatology Research · doi:10.1016/j.hepres.2005.09.028 · Cited by 120
Self-citationExistence of GPR40 functioning in a human breast cancer cell line, MCF-7
Yonezawa, T., Katoh, K., & Obara, Y. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.12.175 · Cited by 115
GPR40 agonists for the treatment of type 2 diabetes: life after ‘TAKing’ a hit
Mancini, A. D., & Poitout, V. (2015) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12442 · Cited by 99
“The reasons for TAK-875’s hepatotoxic effects remain unknown; however, GPR40 does not appear to be expressed in the liver [4,5], suggesting that it is probably an indirect phenomenon not related to direct hepatic activation of GPR40.”
BackgroundResultInfluentialEkberg, J. H., Hauge, M., Kristensen, L. V., Madsen, A. N., Engelstoft, M. S., Husted, A.-S., Sichlau, R., Egerod, K. L., Timshel, P., Kowalski, T. J., et al. (2016) · Endocrinology · doi:10.1210/en.2016-1334 · Cited by 101
“FFA1 sensing LCFAs acts in synergy with GPR119 For many years it has been generally believed that it was the sensing of LCFA which was responsible for the strong stimulation of incretins by triglycerides [3–5].”
BackgroundInfluentialSakamoto, Y., Inoue, H., Kawakami, S., Miyawaki, K., Miyamoto, T., Mizuta, K., & Itakura, M. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.076 · Cited by 101
“1C right; [7]), although there were some notable differences (e.”
BackgroundInhibitory potential of fatty acids on key enzymes related to type 2 diabetes
Su, C., Hsu, C., & Ng, L. (2013) · BioFactors · doi:10.1002/biof.1082 · Cited by 97
“Oleic acid, linoleic acid, a-linolenic acid, c-linolenic acid, arachidonic acid, and docosahexaenoic acid have been shown to stimulate insulin secretion in MIN6 cells [22], and have antidiabetic activity [4,11].”
BackgroundIdentification and characterization of the bovine G protein-coupled receptor GPR41 and GPR43 genes
Wang, A., Gu, Z., Heid, B., Akers, R. M., & Jiang, H. (2009) · Journal of Dairy Science · doi:10.3168/jds.2009-2037 · Cited by 98
“These cells were chosen because they are easy to transfect, provide stable and accurate posttranslational modification, and contain components for typical GPR signaling but no endogenous GPR41 or GPR43 (Itoh et al., 2003; Le Poul et al., 2003; Doupnik et al., 2004).”
Hypothalamic Insulin Resistance in Obesity: Effects on Glucose Homeostasis
Chen, W., Balland, E., & Cowley, M. A. (2017) · Neuroendocrinology · doi:10.1159/000455865 · Cited by 97
The role of GPCRs in bone diseases and dysfunctions
Luo, J., Sun, P., Siwko, S., Liu, M., & Xiao, J. (2019) · Bone Research · doi:10.1038/s41413-019-0059-6 · Cited by 99
Glucose-dependent insulinotropic polypeptide (GIP)
Müller, T. D., Adriaenssens, A. E., Ahrén, B., Blüher, M., Birkenfeld, A. L., Campbell, J. E., Coghlan, M. P., D’Alessio, D. D., Deacon, C. F., DelPrato, S., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102118 · Cited by 113
Identification of G protein-coupled receptor 120-selective agonists derived from PPARγ agonists
Suzuki, T., Igari, S.-I., Hirasawa, A., Hata, M., Ishiguro, M., Fujieda, H., Itoh, Y., Hirano, T., Nakagawa, H., Ogura, M., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800970b · Cited by 101
Self-citationInoue, D., Kimura, I., Wakabayashi, M., Tsumoto, H., Ozawa, K., Hara, T., Takei, Y., Hirasawa, A., Ishihama, Y., & Tsujimoto, G. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.04.021 · Cited by 99
Zeng, Y., Jiang, W., Liu, Y., Wu, P., Zhao, J., Jiang, J., Kuang, S., Tang, L. Y., Tang, W.-N., Zhang, Y., et al. (2015) · Aquaculture Nutrition · doi:10.1111/anu.12337 · Cited by 100
Schilperoort, M., van Dam, A. D., Hoeke, G., Shabalina, I. G., Okolo, A., Hanyaloglu, A. C., Dib, L. H., Mol, I. M., Caengprasath, N., Chan, Y., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708047 · Cited by 100
“GPR40 is involved in insulin secretion and glucose metabolism (Itoh et al, 2003; ElAzzouny et al, 2014), and GPR40 KO mice develop obesity, glucose intolerance, and insulin resistance (Kebede et al, 2008).”
Backgroundβ-Arrestin Recruitment and Biased Agonism at Free Fatty Acid Receptor 1
Mancini, A. D., Bertrand, G., Vivot, K., Carpentier, É., Tremblay, C. C., Ghislain, J. J., Bouvier, M., & Poitout, V. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.644450 · Cited by 106
“The free fatty acid receptor 1/G protein-coupled receptor 40 (FFAR1/GPR40) is a cell surface, seven-transmembrane domain receptor (7TMR)(4) activated by medium-to-long chain FFAs (1, 2).”
BackgroundTomita, T., Masuzaki, H., Iwakura, H., Fujikura, J., Noguchi, M., Tanaka, T., Ebihara, K., Kawamura, J., Komoto, I., Kawaguchi, Y., et al. (2006) · Diabetologia · doi:10.1007/s00125-006-0193-8 · Cited by 107
“Several investigators have recently demonstrated that fatty acids act as ligands for membrane-bound G-proteincoupled receptors such as GPR40 [3, 6, 7], GPR41, GPR43 [8, 9] and GPR120 [10].”
BackgroundInfluentialOleic acid promotes MMP-9 secretion and invasion in breast cancer cells
Soto-Guzmán, A., Navarro‐Tito, N., Castro‐Sánchez, L., Martinez-Orozco, R., & Salazar, E. P. (2010) · Clinical & Experimental Metastasis · doi:10.1007/s10585-010-9340-1 · Cited by 114
“[10, 12, 20], our findings suggest that OA induces MMP-9 secretion via GPR40 activation coupled with Gq or that OA induces GPR120 activation, because GPR120 is the receptor for medium and long chain FFAs, such as OA [11].”
BackgroundSawada, T., Tsubata, H., Hashimoto, N., Takabe, M., Miyata, T., Aoki, K., Yamashita, S., Oishi, S., Osue, T., Yokoi, K., et al. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0437-y · Cited by 97
“The recent experiments have revealed that n-3 PUFA act as ligands of several G-protein- coupled receptors (GPCRs) including GPCR 40 on pancreatic β cells and GPCR 120 on enteroendocrine cells of gastrointestinal tract [24, 25].”
Backgroundde Souza, J., Preseault, C. L., & Lock, A. L. (2017) · Journal of Dairy Science · doi:10.3168/jds.2017-13460 · Cited by 111
Briant, L. J. B., Dodd, M. S., Chibalina, M. V., Rorsman, N. J. G., Johnson, P. R. V., Carmeliet, P., Rorsman, P., & Knudsen, J. G. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.035 · Cited by 98
“In the islet, FFAs are known to regulate glucose-induced insulin secretion independently of b-oxidation via G-protein-coupled receptor GPR40 signaling (Itoh et al., 2003).”
BackgroundNew Insights into Fatty Acid Modulation of Pancreatic β‐Cell Function
Haber, E. P., Procópio, J., Carvalho, C. R. D. O., Carpinelli, Â. R., Newsholme, P., & Curi, R. (2006) · International review of cytology · doi:10.1016/s0074-7696(06)48001-3 · Cited by 112
Li, Z., Xu, X. J., Huang, W., & Qian, H. (2017) · Medicinal Research Reviews · doi:10.1002/med.21441 · Cited by 102
A Click Cage: Organelle‐Specific Uncaging of Lipid Messengers
Wagner, N., Stephan, M., Höglinger, D., & Nadler, A. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201807497 · Cited by 97
Araki, T., Hirayama, M., Hiroi, S., & Kaku, K. (2012) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01525.x · Cited by 96
“G protein-coupled receptor 40 [GPR40, also known as free fatty acid receptor 1 (FFAR1)] [8] is highly expressed in pancreatic β-cells and activated by long-chain free fatty acids (FFAs) [9,10].”
BackgroundEffects of high-fat diet exposure during fetal life on type 2 diabetes development in the progeny
Gniuli, D., Calcagno, A., Caristo, M. E., Mancuso, A., Macchi, V., Mingrone, G., & Vettor, R. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800033-jlr200 · Cited by 97
Kaku, K., Araki, T., & Yoshinaka, R. (2012) · Diabetes Care · doi:10.2337/dc12-0872 · Cited by 98
Free Fatty Acid Receptors (FFARs) in Adipose: Physiological Role and Therapeutic Outlook
Al Mahri, S., Malik, S. S., Al Ibrahim, M., Haji, E., Dairi, G., & Mohammad, S. (2022) · Cells · doi:10.3390/cells11040750 · Cited by 93
Antonietta Ajmone‐Cat, M., Lavinia Salvatori, M., De Simone, R., Mancini, M., Biagioni, S., Bernardo, A., Cacci, E., & Minghetti, L. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.22783 · Cited by 97
“…of the G protein-coupled receptors GPR40 and GPR120 as putative receptors for DHA and other PUFAs in several cell types (Briscoe et al., 2003; Itoh et al., 2003; Kotarsky et al., 2003; Kaplamadzhiev et al., 2010; Oh et al., 2010) raises the possibility that DHA activates these GPRs or…”
BackgroundMolecular docking and molecular dynamics simulation studies of GPR40 receptor–agonist interactions
Lu, S., Jiang, Y., Lv, J. H., Wu, T., Yu, Q., & Zhu, W. (2010) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2010.02.001 · Cited by 102
“The G-protein coupled receptor GPR40, recently named free fatty acid receptor 1 (FFAR1), is predominantly expressed in human and rodent pancreatic islets and is activated by physiological concentrations of medium- and long-chain free fatty acids (FFAs) found in plasma such as linoleic and palmitic acids [3].”
BackgroundLin, D. C.-H., Zhang, J., Zhuang, R., Li, F., Nguyen, K., Chen, M., Tran, T., Lopez, E., Lu, J. Y. L., Li, X. N., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027270 · Cited by 103
“acids to acutely stimulate insulin and incretin secretion [1,2,3].”
BackgroundChristensen, L. W., Kuhre, R. E., Janus, C., Svendsen, B., & Holst, J. J. (2015) · Physiological Reports · doi:10.14814/phy2.12551 · Cited by 99
“Thus, selective FFAR1 activation should theoretically give rise to a robust glucose-stimulated insulin secretion (GSIS) as the b-cells would be both directly and indirectly (incretins) activated.”
InfluentialThe Pancreatic β-Cell: A Bioenergetic Perspective
Nicholls, D. G. (2016) · Physiological Reviews · doi:10.1152/physrev.00009.2016 · Cited by 98
Mechanisms of Omega-3 Polyunsaturated Fatty Acids in Prostate Cancer Prevention
Gu, Z., Suburu, J., Chen, H., & Chen, Y. Q. (2013) · BioMed Research International · doi:10.1155/2013/824563 · Cited by 102
Ravnskjær, K., Frigerio, F., Boergesen, M., Nielsen, T., Maechler, P., & Mandrup, S. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m001123 · Cited by 110
Molecular Basis of Health and Disease
Das, U. N. (2011) · Springer eBooks · doi:10.1007/978-94-007-0495-4 · Cited by 104
Arachidonic acid and lipoxin A4 as possible endogenous anti-diabetic molecules
Das, U. N. (2013) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2012.11.009 · Cited by 99
FFAR1 Is Involved in Both the Acute and Chronic Effects of Palmitate on Insulin Secretion
Kristinsson, H., Smith, D. M., Bergsten, P., & Sargsyan, E. (2013) · Endocrinology · doi:10.1210/en.2013-1352 · Cited by 95
Joseph, J., Depp, C., Shih, P.-A. B., Cadenhead, K. S., & Schmid-Schönbein, G. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00155 · Cited by 95
“GPR40 receptors are expressed in pancreatic beta cells and regulate insulin secretion (Itoh et al., 2003).”
BackgroundLipotoxicity and β Cell Maintenance in Obesity and Type 2 Diabetes
Ye, R., Onodera, T., & Scherer, P. E. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2018-00372 · Cited by 103
Liu, B., Kongstad, K. T., Wiese, S., Jäger, A. K., & Stærk, D. (2016) · Food Chemistry · doi:10.1016/j.foodchem.2016.02.001 · Cited by 101
Imai, Y., Cousins, R. S., Liu, S., Phelps, B. M., & Promes, J. A. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14037 · Cited by 100
A Novel Antidiabetic Drug, Fasiglifam/TAK-875, Acts as an Ago-Allosteric Modulator of FFAR1
Yabuki, C., Komatsu, H., Tsujihata, Y., Risa, M., Ito, R., Kae, M.-N., Sakuma, K., Miyawaki, K., Kikuchi, N., Takeuchi, K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076280 · Cited by 101
“Increasing evidence demonstrates that FFAs augment glucose-stimulated insulin secretion (GSIS) in pancreatic b cells by activating FFAR1 [1,2].”
BackgroundSelf-citation
Metadata
- Authors
- Itoh, Y., Kawamata, Y., Harada, M., Kobayashi, M., Fujii, R., Fukusumi, S., Ogi, K., Hosoya, M., Tanaka, Y., Uejima, H., Tanaka, H., Maruyama, M., Satoh, R., Okubo, S., Kizawa, H., Komatsu, H., Matsumura, F., Noguchi, Y., Shinohara, T., Hinuma, S., Fujisawa, Y., & Fujino, M.
- Affiliations
- Takeda (Japan) (JP)
- Corresponding author
- Hinuma, Shuji
- ORCID
- Venue
- Nature
- Published
- 2003-02-23
- Volume
- 422
- Issue
- 6928
- Pages
- 173-176
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2128326754
- Cited by
- 1,538
- References
- 26
- Citations by year
- 2026: 21 · 2025: 50 · 2024: 54 · 2023: 51 · 2022: 58 · 2021: 89 · 2020: 74 · 2019: 75 · 2018: 88 · 2017: 89 · 2016: 111 · 2015: 82 · 2014: 84 · 2013: 91 · 2012: 84
- FWCI
- 45.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- free fatty acids, GPR40, insulin secretion, pancreatic beta cells, glucose-stimulated insulin secretion, long-chain fatty acids, G protein-coupled receptors, diabetes mellitus, antidiabetic drug development
- MeSH terms
- Insulin Secretion, Animals, Haplorhini, Calcium, Enzyme Activation, Fatty Acids, Nonesterified, Glucose, Cricetinae, Humans, Insulin, Male, Molecular Sequence Data, Pancreas, Receptors, Cell Surface, RNA, Messenger, Transfection, CHO Cells, Rats, Wistar, Calcium Signaling, Mitogen-Activated Protein Kinases, MAP Kinase Signaling System, RNA, Small Interfering, Receptors, G-Protein-Coupled, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.